JG
EGRX

Joel Greenblatt’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Joel Greenblatt’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,986
Closed -$232K – 1115
2020
Q4 		$232K Buy
+4,986
New +$233K 0.01% 896
2020
Q3 		– Sell
-5,304
Closed -$254K – 1155
2020
Q2 		$254K Sell
5,304
-19,996
-79% -$998K 0.01% 900
2020
Q1 		$1.16M Sell
25,300
-11,290
-31% -$567K 0.03% 516
2019
Q4 		$2.2M Sell
36,590
-6,178
-14% -$368K 0.04% 450
2019
Q3 		$2.42M Buy
42,768
+8,586
+25% +$483K 0.04% 422
2019
Q2 		$1.9M Buy
34,182
+12,550
+58% +$655K 0.03% 516
2019
Q1 		$1.09M Buy
21,632
+16,266
+303% +$724K 0.02% 637
2018
Q4 		$216K Sell
5,366
-4,837
-47% -$249K ﹤0.01% 924
2018
Q3 		$707K Sell
10,203
-4,166
-29% -$316K 0.01% 676
2018
Q2 		$1.09M Sell
14,369
-2,675
-16% -$168K 0.02% 580
2018
Q1 		$898K Sell
17,044
-35,197
-67% -$2.05M 0.01% 629
2017
Q4 		$2.79M Sell
52,241
-124,895
-71% -$6.95M 0.04% 439
2017
Q3 		$10.6M Buy
177,136
+1,922
+1% +$116K 0.16% 213
2017
Q2 		$13.8M Buy
175,214
+30,202
+21% +$2.47M 0.19% 169
2017
Q1 		$12M Buy
145,012
+57,583
+66% +$4.28M 0.15% 227
2016
Q4 		$6.94M Buy
87,429
+47,951
+121% +$3.48M 0.09% 316
2016
Q3 		$2.76M Buy
+39,478
New +$2.19M 0.04% 448
2015
Q3 		– Sell
-18,945
Closed -$1.53M – 1064
2015
Q2 		$1.53M Buy
+18,945
New +$1.23M 0.01% 574

Other funds holding EGRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
SGCIA
Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Joel Greenblatt's EGRX Position: Q1 2021 in Review

Joel Greenblatt sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2021, closing a stake of 4,986 shares — an estimated $232K sold.

Joel Greenblatt first reported a position in EGRX in Q2 2015 and held it in 18 quarters. The position peaked at $13.8M in Q2 2017. 155 funds tracked by Wall St. Rank hold EGRX as of Q1 2021.

  • Joel Greenblatt reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Joel Greenblatt sold 4,986 Eagle Pharmaceuticals, Inc. shares in Q1 2021, an estimated $232K.
  • Joel Greenblatt first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 18 quarters.
  • Joel Greenblatt's Eagle Pharmaceuticals, Inc. position peaked at $13.8M in Q2 2017.
  • 155 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2021.

Based on Gotham Asset Management's 13F filing for Q1 2021, filed 17 May 2021.